• Out-of-Stock
  • Save €1.81


  • 003452048

Indicated in case of nausea and vomiting.

Indicated in case of seasickness, car sickness and train sickness.

Deductible over-the-counter drug.

From 2 years of age.

info_outline View product sheet
Final Price €5.09
Regular Price €6.90
Save €1.81
error Out-of-Stock

Notify me when available

  Convenient and safe payments

Even with a credit card

  Shipping in 48h-72h all over the world

FREE in Italy over € 39.90

  Fast returns

14 days to reconsider

  Pharmaceutical experience

Always at your service

Antihistamines and Decongestants Others products at unbeatable price


Discover all products


Therapeutic indications

Prevention and treatment of nausea, vomiting and vertigo, typical of naupathias (seasickness, car, train, plane sickness).

Dosage and method of use

In children aged 2-6 years: 1 tablet or 1 suppository of VALONTAN children up to a maximum of 3 times a day, as needed. In children aged 7-12 years: 1-2 tablets or suppositories of VALONTAN children 2-3 times a day. It is recommended to take about 30 minutes before obtaining the desired effect. Do not administer to children under 2 years of age (see 4.3) Do not exceed the recommended dose. Do not use for prolonged treatments.


Hypersensitivity to the active substance or to any of the excipients. Contraindicated in children under 2 years of age. Generally contraindicated during pregnancy and lactation.

Side effects

The most frequent side effect of antihistamines is sedation which can manifest as drowsiness. Dry mouth, photosensitivity, accommodation disorders, urination disorders, headache, anorexia, nausea, allergic skin reactions may occur with the use of antihistamines. Less frequently dizziness, asthenia, insomnia (especially in children), euphoria, tremors, hypotension, tachycardia and, at high doses, especially in children, convulsions.

Special warnings

The use of antihistamines at the same time as certain antibiotics or other ototoxic drugs can mask the early signs of ototoxicity, which can only reveal itself when the damage is irreversible. Use with caution in subjects suffering from glaucoma, prostatic hypertrophy, other urinary retention syndromes, intestinal obstruction, arterial hypertension, cardiovascular disease, bronchial asthma, chronic bronchitis or emphysema, hyperthyroidism. The medicine can exacerbate seizure disorders. It should therefore be used with great caution in subjects suffering from epilepsy. The tablets contain sucrose and are therefore not suitable for people with hereditary fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase deficiency.

Pregnancy and breastfeeding

It is not recommended for use during pregnancy. In breastfeeding patients, it is necessary to decide whether to give up breastfeeding the baby and start the treatment or, vice versa, continue breastfeeding avoiding the administration of the product.

Expiry and retention


Interactions with other drugs

During the treatment, in order to prevent additive phenomena of sedation, it is necessary to avoid that the child is given drugs that act on the Central Nervous System.


Sleepiness is the most usual symptom of overdosing. Toxic doses can produce: convulsions, coma and respiratory depression. If necessary, implement symptomatic therapy; when necessary, respiratory assistance.

Active principles

Coated tablets : Each coated tablet contains: Active ingredient Dimenhydrinate 25 mg Suppositories : Each suppository contains : Active ingredient Dimenhydrinate 25 mg For excipients: see 6.1


Coated tablets : Each coated tablet contains: Excipients: Sucrose 15.0 mg, polyvinylpyrrolidone 2.0 mg, precipitated silica 1.5 mg, magnesium stearate 1.5 mg, corn starch 45.0 mg, hydroxypropylmethylcellulose 1.875 mg, polyethylene glycol 400 0.1875 mg, titanium dioxide 0.9375 mg. Suppositories : Each suppository contains: Excipients: 10 mg precipitated silica, 1500 mg semisynthetic glycerides.